Cite Filings / AMLX / 0000899243-22-016836

Feed Companies Filings Check

Sign in

3

Initial Statement of Ownership

Amylyx Pharmaceuticals, Inc. Filed 2022-05-05 Acc 0000899243-22-016836

Documents 1

3 Initial Statement of Ownership , xslF345X02/doc3.xml

Around this filing

2023-03-20 3 Initial Statement of Ownership
2022-05-06 4 Co-Chief Executive Officer acquired 334,520 shares (option exercise)
2022-05-06 4 Co-Chief Executive Officer acquired 334,520 shares (option exercise)
2022-05-05 4 10% owner acquired 5,955,889 shares (conversion)
2022-05-05 3 Initial Statement of Ownership
2022-04-29 DEFA14A Proxy Materials
2022-02-28 3 Initial Statement of Ownership

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xslF345X02/doc3.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…